Orchestra BioMed Holdings, Inc. (OBIO) — Institutional Holders & Catalysts | BiotechEdge

Catalysts Convergence Squeeze Signals Cash Runway Insiders Research

Home›Companies›Orchestra BioMed Holdings, Inc. (OBIO)

Orchestra BioMed Holdings, Inc.

OBIO

Held by 2 specialist biotech funds

2 funds opened new positions. Short interest: 2.0% of float.

Score Holdings Short Interest Catalysts Insiders Research

Signal Score

4.0/10

2 funds opened new positions

BiotechEdge

Catalysts Conferences Companies Convergence Fund Insiders Signals Squeeze Cash Runway Research Weekly Briefs 13F Changes Glossary PricingSign In Start 14-Day Free Trial

Data sourced from SEC EDGAR and ClinicalTrials.gov. Not investment advice.

Feedback

●●

No recent insider activity●●

No upcoming catalysts●●

Held by 2 specialist funds●●

See how each signal contributes— fund overlap, insider activity, catalyst timing, short interest (free trial)

Fund Holdings

RTW InvestmentsHeld 4Q

Perceptive AdvisorsHeld 4Q ↑

Position history (shares)

RTW Investments

Perceptive Advisors

4 quarters

Position Trend

Aug 6, 2025

$19.7M

1 fund

Aug 14, 2025

$34.6M

2 funds

Nov 14, 2025

$33.7M

2 funds

Feb 17, 2026

$55.7M

2 funds

+59% total institutional value over 5 quarters

Short Interest

Short Shares

795K

Change

+4.6%

Days to Cover

3.7

% of Float

2.0%

Settlement

Mar 13, 2026

Short interest over 2 periods

Catalysts

No catalysts tracked.

Activist Filings

SC 13D/ARTW Investments19.7%Feb 25, 2026

SC 13G/APerceptive Advisors10.0%Nov 14, 2025

SC 13D/ARTW Investments15.4%Aug 6, 2025

SC 13D/ARTW Investments21.7%May 1, 2025

SC 13D/ARTW Investments21.5%Aug 7, 2024

SC 13G/APerceptive Advisors12.8%Jul 17, 2024

SC 13G/APerceptive Advisors6.8%Feb 14, 2024

SC 13GPerceptive Advisors6.8%Sep 13, 2023

SC 13D/ARTW Investments15.7%May 5, 2023

SC 13GRA Capital Management5.4%Feb 14, 2023

SC 13D/ARTW Investments16.2%Jan 27, 2023

Position Details

RTW InvestmentsFeb 17, 2026

Start free trialfor share counts, dollar values & AI analysis

7 more position changes — start your free trial to see dollar values and AI analysis for all of them.

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 14-Day Free Trial — $29/mo

Insider Signals

No insider purchases or sales detected in the past 90 days.

Also Held by These Funds

AAVXF2 funds AQST2 funds CELC2 funds KOD2 funds CRVS2 funds KYMR2 funds BBNX2 funds LENZ2 funds

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Related Research

Verdad's Biotech White Paper, Part 1: Why Specialist Fund Holdings Predict Returns

6 min read

Verdad's Biotech White Paper, Part 2: Why Traditional Quant Factors Fail — and What Works Instead

6 min read

Fund Convergence: The Highest-Conviction Signal in Biotech Investing

5 min read

Track specialist biotech funds, insider signals, and AI analysis

Start 14-Day Free Trial

Get free weekly alerts on fund moves and catalysts:

Terms

Privacy

Disclaimer